GLS and pancreatic neoplasm: Nuclear-enriched antisense lncRNA of glutaminase (GLS-AS) binds to GLS pre-mRNA via ADAR/Dicer-dependent RNA interference to form double-stranded RNA and inhibit GLS expression in pancreatic cancer cell lines.